Abiopharma

New Form 10-Q - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-08-08 AccNo: 0001628280-25-039326 Size: 4 MB

New Form 144 - AbbVie Inc. Filed: 2025-08-08 AccNo: 0001415889-25-021352 Size: 9 KB

New Form S-1 - SeaStar Medical Holding Corp Filed: 2025-08-08 AccNo: 0001213900-25-073745 Size: 13 MB

Ashland board authorizes quarterly dividend

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 10-Q - Actinium Pharmaceuticals, Inc. Filed: 2025-08-08 AccNo: 0001213900-25-073743 Size: 4 MB

New Form 8-K for Quantum-Si Incorporated

Puma Biotechnology, Inc. - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 3 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-08 AccNo: 0001161697-25-000221 Size: 5 KB

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000105 Size: 19 KB

Simulations Plus, Inc. (SLP) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000104 Size: 14 KB

New Form 8-K - Earth Science Tech, Inc. Filed: 2025-08-08 AccNo: 0001641172-25-022803 Size: 244 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits